Parmar Kush's Form 4 filing
Camp4 Therapeutics Corp (CAMP) · filed Sep 15, 2025
- Accession no.
- 0001231919-25-000196
- Filed
- Sep 15, 2025, 8:12 PM ET
- Trade date
- Sep 11, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $4.50M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Parmar KushCIK 0001664281 | 10% Owner |
| 5AM Ventures VI, L.P.CIK 0001753037 | 10% Owner |
| 5AM Partners VI, LLCCIK 0001829051 | 10% Owner |
| 5AM Opportunities II, L.P.CIK 0001844401 | 10% Owner |
| 5AM Ventures VII, L.P.CIK 0001844435 | 10% Owner |
| 5AM Opportunities II (GP), LLCCIK 0001873515 | 10% Owner |
| 5AM Partners VII, LLCCIK 0001873545 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | Common Stock | PPurchaseAcquired | +2,941,176 | $1.53 | +$4,499,999.28 | 2,941,176 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.